Pharmaceutical

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information

Conference Call Scheduled for Friday, February 14 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - February 13, 2025) - Elite…

10 months ago

Epicured Named to the 2025 New York Digital Health 100 by Digital Health New York (DHNY)

DH100 recognizes those companies that have helped make New York the capital of healthcare innovation NEW YORK, Feb. 13, 2025…

10 months ago

bioMérieux Launches GENE-UP® TYPER,an Innovative Diagnostic Solution for Food Industries to Rapidly Analyze the Root Causeof Contamination of Listeria monocytogenes

Real-Time PCR* Solution Combines an Assay and a Web Application for Rapid Strain Characterization to Quickly Identify Root Cause Contamination…

10 months ago

T-CURX GmbH Enters into Technology Access Agreement with Kytopen

Kytopen announces expansion of its partnership program into Europe with its agreement with T-CURX GmbH, a biotech company based in…

10 months ago

U.S. product recalls reach second-highest level in six years during 2024

Sedgwick brand protection releases year-in-review analysis of 2024 recall data MEMPHIS, Tenn., Feb. 13, 2025 /PRNewswire/ -- The number of…

10 months ago

MOBILion Systems to Present Advanced Proteomics Capabilities with New PAMAF Operating Mode at US HUPO 2025

CHADDS FORD, Pa., Feb. 13, 2025 /PRNewswire/ -- MOBILion Systems, Inc., a leader in separation science innovation, today announced its participation…

10 months ago

Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston April 3, 2025 with Expanded AI Focus

Participants to Enjoy Access to 24th Annual Bio-IT World Conference & Expo, Running Concurrently April 2-4 BOSTON, Feb. 13, 2025…

10 months ago

Lindus Health and CDISC Collaborate on Innovative AI Initiative to Standardize Clinical Trial Data for Accelerated Research

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, has announced their…

10 months ago

Augustine Therapeutics appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the Clinic

Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the Clinic Industry veteran Gerhard Koenig, PhD,…

10 months ago